These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 15727504

  • 1. Discriminative stimulus and self-reported effects of methylphenidate, d-amphetamine, and triazolam in methylphenidate-trained humans.
    Stoops WW, Lile JA, Glaser PE, Rush CR.
    Exp Clin Psychopharmacol; 2005 Feb; 13(1):56-64. PubMed ID: 15727504
    [Abstract] [Full Text] [Related]

  • 2. Oxazepam does not modulate the behavioral effects of d-amphetamine in humans.
    Lile JA, Stoops WW, Wagner FP, Glaser PE, Rush CR.
    Pharmacol Biochem Behav; 2005 Oct; 82(2):270-9. PubMed ID: 16182353
    [Abstract] [Full Text] [Related]

  • 3. Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans.
    Sevak RJ, Stoops WW, Hays LR, Rush CR.
    J Pharmacol Exp Ther; 2009 Mar; 328(3):1007-18. PubMed ID: 19104030
    [Abstract] [Full Text] [Related]

  • 4. Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans.
    Rush CR, Kollins SH, Pazzaglia PJ.
    Exp Clin Psychopharmacol; 1998 Feb; 6(1):32-44. PubMed ID: 9526144
    [Abstract] [Full Text] [Related]

  • 5. Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans.
    Lile JA, Stoops WW, Durell TM, Glaser PE, Rush CR.
    Exp Clin Psychopharmacol; 2006 May; 14(2):136-47. PubMed ID: 16756417
    [Abstract] [Full Text] [Related]

  • 6. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.
    Rush CR, Madakasira S, Goldman NH, Woolverton WL, Rowlett JK.
    J Pharmacol Exp Ther; 1997 Jan; 280(1):174-88. PubMed ID: 8996195
    [Abstract] [Full Text] [Related]

  • 7. Functional antagonism of the caffeine-discriminative stimulus by triazolam in humans.
    Oliveto AH, Bickel WK, Hughes JR, Higgins ST, Badger G.
    Behav Pharmacol; 1997 Jun; 8(2-3):124-38. PubMed ID: 9833008
    [Abstract] [Full Text] [Related]

  • 8. Effects of d-amphetamine and caffeine in humans under a cocaine discrimination procedure.
    Oliveto AH, McCance-Katz E, Singha A, Hameedi F, Kosten TR.
    Behav Pharmacol; 1998 May; 9(3):207-17. PubMed ID: 9832935
    [Abstract] [Full Text] [Related]

  • 9. Behavioral pharmacological similarities between methylphenidate and cocaine in cocaine abusers.
    Rush CR, Baker RW.
    Exp Clin Psychopharmacol; 2001 Feb; 9(1):59-73. PubMed ID: 11519636
    [Abstract] [Full Text] [Related]

  • 10. A novel-response procedure enhances the selectivity and sensitivity of a triazolam discrimination in humans.
    Bickel WK, Oliveto AH, Kamien JB, Higgins ST, Hughes JR.
    J Pharmacol Exp Ther; 1993 Jan; 264(1):360-7. PubMed ID: 8423538
    [Abstract] [Full Text] [Related]

  • 11. Flumazenil discrimination by humans under a two-response and a novel-response procedure.
    Smith BJ, Bickel WK.
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1257-68. PubMed ID: 10565850
    [Abstract] [Full Text] [Related]

  • 12. Caffeine induces differential cross tolerance to the amphetamine-like discriminative stimulus effects of dopaminergic agonists.
    Jain R, Holtzman SG.
    Brain Res Bull; 2005 May 15; 65(5):415-21. PubMed ID: 15833596
    [Abstract] [Full Text] [Related]

  • 13. [Discriminative stimulus properties of D-amphetamine: a neuropharmacological review].
    Inagawa K.
    Yakubutsu Seishin Kodo; 1992 Aug 15; 12(4):151-65. PubMed ID: 1414035
    [Abstract] [Full Text] [Related]

  • 14. Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans.
    Rush CR, Stoops WW, Hays LR, Glaser PE, Hays LS.
    J Pharmacol Exp Ther; 2003 Jul 15; 306(1):195-204. PubMed ID: 12676890
    [Abstract] [Full Text] [Related]

  • 15. Discriminative stimulus effects of d-amphetamine, methylphenidate, and diazepam in humans.
    Heishman SJ, Henningfield JE.
    Psychopharmacology (Berl); 1991 Jul 15; 103(4):436-42. PubMed ID: 2062984
    [Abstract] [Full Text] [Related]

  • 16. Triazolam-amphetamine interaction: dissociation of effects on memory versus arousal.
    Mintzer MZ, Griffiths RR.
    J Psychopharmacol; 2003 Mar 15; 17(1):17-29. PubMed ID: 12680736
    [Abstract] [Full Text] [Related]

  • 17. Discriminative-stimulus effects of zolpidem, triazolam, pentobarbital, and caffeine in zolpidem-trained humans.
    Rush CR, Baker RW, Rowlett JK.
    Exp Clin Psychopharmacol; 2000 Feb 15; 8(1):22-36. PubMed ID: 10743902
    [Abstract] [Full Text] [Related]

  • 18. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: I. Comparison with triazolam in rhesus monkeys and rats.
    Rowlett JK, Woolverton WL.
    J Pharmacol Exp Ther; 1997 Jan 15; 280(1):162-73. PubMed ID: 8996194
    [Abstract] [Full Text] [Related]

  • 19. Discriminative stimulus properties of intragastrically administered d-amphetamine and pentobarbital in rhesus monkeys.
    de la Garza R, Johanson CE.
    J Pharmacol Exp Ther; 1987 Dec 15; 243(3):955-62. PubMed ID: 2891839
    [Abstract] [Full Text] [Related]

  • 20. Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans.
    Stoops WW, Glaser PE, Fillmore MT, Rush CR.
    J Psychopharmacol; 2004 Dec 15; 18(4):534-43. PubMed ID: 15582920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.